Carvedilol Versus Placebo for Treatment in PTSD (PTSD)
This study evaluates the safety and effectiveness of Carvedilol for people with PTSD.
Understand this study
What is this study about?
This study evaluates the safety and effectiveness of Carvedilol for people with PTSD.
Who could participate?
This study is for people with PTSD. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
- Listed locations
- San Diego and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 80
- Sponsor
- Columbia Northwest Pharmaceuticals
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT01221792
- Official title
Show the full official title
A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Study to Assess the Safety and Efficacy of Carvedilol Versus Placebo in the Treatment of Post Traumatic Stress Disorder
Recruitment & locations
San Diego · Lake Charles · Bellevue
Interested in joining this study?
Questions about this study
What is this study about?
This study evaluates the safety and effectiveness of Carvedilol for people with PTSD.
Who is behind this study?
The study sponsor is Columbia Northwest Pharmaceuticals.
Does this study involve medication?
Yes. The study involves medication, including Carvedilol and Placebo.
Who can participate?
This study is for people with PTSD. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
